{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:00:53Z","timestamp":1790600453935,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clae.2026.102843","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:47:17Z","timestamp":1789897637000},"page":"102843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the efficacy of topical tea tree oil versus preservative-free azithromycin in the treatment of dry eye disease associated with meibomian gland dysfunction: A randomized controlled trial focusing on tear interleukin levels"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-4637","authenticated-orcid":false,"given":"Dalia R.","family":"El-Afify","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7506-972X","authenticated-orcid":false,"given":"Rewan H.H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-2517","authenticated-orcid":false,"given":"Fedaa A.","family":"Kotkata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5481-5318","authenticated-orcid":false,"given":"Tamer I.","family":"Abdelhalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-9616","authenticated-orcid":false,"given":"Ehab Mohamed Elsayed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2026.102843_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clae.2026.102843_bb0010","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/opo.12888","article-title":"The global prevalence of dry eye disease: a Bayesian view","volume":"41","author":"Papas","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clae.2026.102843_bb0015","article-title":"Dry eye disease prevalence and associated risk factors among the Middle East population: a systematic review and meta-analysis","volume":"16","author":"Mohamed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.clae.2026.102843_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.clae.2026.102843_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.18773\/austprescr.2018.048","article-title":"Dry eye disease: when to treat and when to refer","volume":"41","author":"Findlay","year":"2018","journal-title":"Aust Prescr"},{"key":"10.1016\/j.clae.2026.102843_bb0030","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4103\/IJO.IJO_2841_22","article-title":"Evaporative dry eye disease due to meibomian gland dysfunction: preferred practice pattern guidelines for diagnosis and treatment","volume":"71","author":"Narang","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2026.102843_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/tjo.tjo_56_19","article-title":"Role of tear film biomarkers in the diagnosis and management of dry eye disease","volume":"9","author":"Fong","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0045","article-title":"Multidimensional immunotherapy for dry eye disease: current status and future directions","volume":"4","author":"Huang","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.clae.2026.102843_bb0050","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s40123-023-00669-1","article-title":"Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape","volume":"12","author":"Sheppard","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.clae.2026.102843_bb0055","article-title":"Global research hotspots and trends in anti-inflammatory studies in dry eye: a bibliometric analysis (2004\u20132024)","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clae.2026.102843_bb0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40123-025-01129-8","article-title":"Optimizing diagnosis and management of dry eye disease: a practical framework for Hong Kong","volume":"14","author":"Lam","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.clae.2026.102843_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ICL.0000000000000729","article-title":"Efficacy of azithromycin eyedrops for individuals with meibomian gland dysfunction-associated posterior blepharitis","volume":"47","author":"Arita","year":"2021","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clae.2026.102843_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1116077","article-title":"Efficacy and safety of Melaleuca alternifolia (tea tree) oil for human health\u2014a systematic review of randomized controlled trials","volume":"14","author":"Kairey","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clae.2026.102843_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.011","article-title":"Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: a randomized clinical trial","volume":"44","author":"\u00c1vila","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.clae.2026.102843_bb0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00011-014-0749-x","article-title":"Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1\u03b2, IL-6 and IL-10 on human macrophages","volume":"63","author":"Nogueira","year":"2014","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clae.2026.102843_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","article-title":"Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties","volume":"19","author":"Carson","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.clae.2026.102843_bb0090","first-page":"1","article-title":"TFOS DEWS II and beyond-utilising evidence base to inform the management of dry eye disease","volume":"20","author":"Craig","year":"2019","journal-title":"Optom Pract"},{"issue":"2","key":"10.1016\/j.clae.2026.102843_bb0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3758\/BRM.40.2.484","article-title":"A program for generating randomized simple and context-sensitive sequences","volume":"40","author":"Remillard","year":"2008","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.clae.2026.102843_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","article-title":"A review of quality of life measures in dry eye questionnaires","volume":"33","author":"Grubbs","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2026.102843_bb0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamaophthalmol.2013.4503","article-title":"Development and validation of the dry eye-related quality-of-life score questionnaire","volume":"131","author":"Sakane","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2016.06.025","article-title":"Development of definitive and reliable grading scales for meibomian gland dysfunction","volume":"169","author":"Arita","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0115","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1167\/iovs.13-12132","article-title":"Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures","volume":"54","author":"Wei","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2026.102843_bb0120","article-title":"Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clae.2026.102843_bb0125","first-page":"155","article-title":"Topical tea tree oil versus systemic azithromycin in the treatment of posterior marginal blepharitis","volume":"42","author":"Elgazzar","year":"2025","journal-title":"Benha Med J"},{"key":"10.1016\/j.clae.2026.102843_bb0130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/09273948.2019.1644349","article-title":"Comparison of efficacy and safety of two tea tree oil-based formulations in patients with chronic blepharitis: a double-blinded randomized clinical trial","volume":"28","author":"Ergun","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clae.2026.102843_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-025-02241-6","article-title":"Pharmacological, natural and emerging therapies for meibomian gland dysfunction: a review","author":"Cooper","year":"2026","journal-title":"Drugs"},{"key":"10.1016\/j.clae.2026.102843_bb0140","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3346\/jkms.2011.26.7.938","article-title":"Interleukin-17 in various ocular surface inflammatory diseases","volume":"26","author":"Kang","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clae.2026.102843_bb0145","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/ICO.0000000000002506","article-title":"Effects of terpinen-4-ol on meibomian gland epithelial cells in vitro","volume":"39","author":"Chen","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2026.102843_bb0150","article-title":"The varied influence of ocular Demodex infestation on dry eye disease and meibomian gland dysfunction across different age groups","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.clae.2026.102843_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02610-9","article-title":"The correlation between Demodex infestation and meibomian gland dysfunction at different ages","volume":"22","author":"Sun","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1645\/18-46","article-title":"Evaluation of the efficacy of tea tree oil on the density of Demodex mites (Acari: Demodicidae) and ocular symptoms in patients with demodectic blepharitis","volume":"104","author":"Karakurt","year":"2018","journal-title":"J Parasitol"},{"key":"10.1016\/j.clae.2026.102843_bb0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/02713683.2021.1978099","article-title":"Different approach to manage Demodex blepharitis \u2013 initial and maintenance treatment","volume":"47","author":"Jacobi","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clae.2026.102843_bb0170","article-title":"Tea tree oil for Demodex blepharitis","volume":"6","author":"Savla","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clae.2026.102843_bb0175","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s10792-020-01489-z","article-title":"Analysis of tear inflammatory molecules and clinical correlations in evaporative dry eye disease caused by meibomian gland dysfunction","volume":"40","author":"Wu","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0180","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1167\/iovs.18-24027","article-title":"The level of inflammatory tear cytokines is elevated in congenital aniridia and associated with meibomian gland dysfunction","volume":"59","author":"Landsend","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2026.102843_bb0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2026.102843_bb0190","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/opo.13330","article-title":"The topical azithromycin meibomian gland dysfunction survey: the effect of topical azithromycin on signs and symptoms of meibomian gland dysfunction","volume":"44","author":"Jarvis","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clae.2026.102843_bb0195","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2026.102843_bb0200","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2023.12.041","article-title":"American Academy of Ophthalmology Preferred Practice Pattern Cornea\/External Disease Panel. Dry eye syndrome preferred practice pattern\u00ae","volume":"131","author":"Amescua","year":"2024","journal-title":"Ophthalmology"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048426002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048426002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:38:22Z","timestamp":1790599102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048426002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1367048426002390"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2026.102843","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the efficacy of topical tea tree oil versus preservative-free azithromycin in the treatment of dry eye disease associated with meibomian gland dysfunction: A randomized controlled trial focusing on tear interleukin levels","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2026.102843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Contact Lens Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102843"}}